Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010.
Emerg Infect Dis
; 18(1): 120-4, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-22264682
ABSTRACT
To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Syncytial Viruses
/
Viral Fusion Proteins
/
Respiratory Syncytial Virus Infections
/
Evolution, Molecular
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Emerg Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2012
Document type:
Article
Affiliation country:
Canadá